Follow RSS for latest reports on this topicBiological Patent - Market Research and Reports

A biological patent is a patent on an invention in the field of biology, thus providing the patentee with the right to exclude others from making, using, selling, or importing the claimed invention in biology for a limited period of time. Patentable entities vary between jurisdictions[1] and may include biological products, genetically modified organisms and genetic material. The applicability of patents for entities wholly or partially natural in origin is a subject of debate.  Source: Wikipedia

BioPortfolio's Easy Ordering System

  1. Search for the report you need from our store
  2. Make online payment with our easy checkout process
  3. Receive PDF report via email

Easy Online Payment or Pro Forma Invoice

We accept the following credit cards...



or can supply a pro-forma invoice if required.

Related Reports:

We found over 40 reports that matched your search.

Next 40 Matches >

Refine your search, and find more matches, using the form above.

Structural Heart Devices Market by Product (Structural Heart Repair Devices and Replacement Valves), Age Group (Pediatric and Adult), and Indication (Atrial Septal Defect (ASD), Patent Foramen Ovale (PFO), Ventricular Septal Defect (VSD), and Aortic Valve Stenosis) [Report Updated: 01-02-2017]

Structural heart disease refers to cardiac defects that are congenital in nature and can also be acquired through wear & tear of heart valves or chambers of the heart. Rapid advancements in the medical field have replaced the open heart surgical procedures with non-surgical minimally invasive procedures such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TM...Read More >>>

Published:
2017-02-01

Published by: Allied Market Research

Prices Starting From:
$5370

Chemical Biological Radiological Nuclear and Explosives (CBRNE) Detection Equipment Market - By System (Radiation Detectors, Spectrometers, Simulators, Others); By Detection (Chemical, Biological and Others); End User (Defense, Aviation, Government, Others)-Forecast (2017-2022) [Report Updated: 19-08-2016]

The Chemical, Biological, Radiological Nuclear and Explosive (CBRNe) materials can be either weaponized or non-weaponized; wherein weaponized materials can be released using bombs or blast weapons and non-weaponized ones are identified through contamination of food, livestock and crops. CBRNe materials when released into environment are considered as hazardous materials (HAZMAT) and the devices us...Read More >>>

Published:
2016-08-19

Published by: Industry ARC

Prices Starting From:
$5250

JP Giants leaning in for becoming a Speciality Global Pharma Sakigake designation – A Push from government to “Innovate”! “Essential drugs” exemption from Z2 rule- Balancing long listed pricing pressure! Authorized Generics, Biosimilars, and Patent Litigations - Avenues to grow in JP Generic market!

Sakigake designation – A Push from government to “Innovate”!“Essential drugs” exemption from Z2 rule- Balancing long listed pricing pressure!Authorized Generics, Biosimilars, and Patent Litigations - Avenues to grow in JP Generic market! Increasing decline in long listed products sales, and a few success in R & D in the last decade had put JP giants under pressure to refocus on Innovatio...Read More >>>

Published:
2016-03-10

Published by: MP Advisors

Prices Starting From:
$2500

Additional Searches

You may also like to search separately for: Biological Patent

We Stock...

{STICKYFOOTERMOBILE}